Related Experiment Videos

Transplantation of human renal carcinomas into athymic mice

Cancer Research
|June 1, 1985
PubMed

Insights

Successful transplantation of human renal cell carcinoma into mice correlated with poorer patient survival. This finding suggests that tumor growth in mice may indicate a more aggressive cancer in humans.

Area of Science:

  • Oncology
  • Cancer Biology
  • Xenograft Models

Background:

  • Renal cell carcinoma (RCC) is a significant cause of cancer-related mortality.
  • Establishing reliable preclinical models is crucial for understanding RCC progression and developing new therapies.
  • Tumor xenografts in immunocompromised mice are widely used for cancer research.

Purpose of the Study:

  • To evaluate the feasibility of transplanting primary human renal cell carcinomas into athymic mice.
  • To investigate the relationship between successful xenograft formation and patient prognosis.
  • To compare the characteristics of human tumors and their corresponding mouse xenografts.

Main Methods:

  • Thirty-one primary human renal cell carcinomas were orthotopically transplanted into athymic mice.
  • Tumor take and growth were monitored.
  • Nuclear grade and cellular histology of human tumors and successful xenografts were compared.
  • Patient survival data was analyzed in relation to successful transplantation.

Main Results:

  • Ten out of thirty-one (32%) primary human renal carcinomas successfully formed tumors in athymic mice.
  • Only tumors with high nuclear grade (3 or 4) were successfully transplanted.
  • While nuclear grade was preserved, cellular histology often differed between the primary tumor and the xenograft.
  • Patients whose tumors successfully formed xenografts had significantly poorer 1-year survival (30%) compared to those whose tumors did not (83%).

Conclusions:

  • Successful xenografting of human renal cell carcinoma in athymic mice is achievable, particularly for high-grade tumors.
  • Successful tumor transplantation is inversely correlated with patient prognosis, suggesting a potential indicator of aggressive disease.
  • This xenograft model may serve as a valuable tool for studying aggressive renal cell carcinoma and testing therapeutic strategies.

Related Concept Videos